📰 Abstracts News
Page 4 - Abstracts News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abstracts. Real-time updates on events, politics, business and more.
May 17, 2023
– Data Across 30 Abstracts Reinforce Leadership in Metastatic Breast Cancer and Demonstrate Breadth of Pipeline Across Lung, Hematologic, Genitourinary, Gastrointestinal, Gynecological and... | May 17, 2023
May 8, 2023
Prelude Therapeutics Announces First Quarter 2023 Financial Results and Operations Update Eight abstracts presented at AACR 2023 demonstrate progress of the pipeline ... | May 8, 2023
May 5, 2023
LYON, France and CAMBRIDGE, Mass., May 05, 2023 (GLOBE NEWSWIRE) -- Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and related diseases, today announced
May 3, 2023
Oral presentation on SAR'579 IPH6101, a potential first-in-class NKp46/CD16-based NK cell engager targeting CD123; SAR'579 IPH6101 is ANKET platform lead asset and under development by partner Sanofi
May 1, 2023
Alcon innovations featured in approximately 180 abstracts across cataract, glaucoma, refractive, visualization and ocular health1 New data demonstrates comparable range of vision and intermediate... | May 1, 2023
May 1, 2023
1,800 abstracts have been accepted to ATC 2023, representing most exciting science in transplantation
May 1, 2023
Veracyte, Inc. today announced that three abstracts focused on the company’s genomic tests for interstitial lung disease and lung cancer will be presented at the American Thoracic Society ... | May 1, 2023
April 29, 2023
How difficult it is when you dont get the likes or you get negative comments. then imagine being 12 or 14 or 15 and dealing with that. >> dr. twangy, quick final thought. you with jonathan hiet and others, youre putting together a hell of a databank on this. its totally transparent. people can go and get this information themselves. >> yeah. we put together several google docs on this. you can read the abstracts of the studies, see some of the graphs. its open to commentary for academics. its al...
April 29, 2023
Then imagine being 12 or 14 or 15 and dealing with that. >> dr. twangy, quick final thought. you, along with others, are putting together a hell of a databank on this. its totally transparent. people can go and get this information themselves. >> yeah. we put together several google docs on this. you can read the abstracts of the studies, see some of the graphs. its open to commentary for academics. its all there. then, of course, a lot of its in the new book as well. check it out. see for yours...
April 26, 2023
FORE Biotherapeutics today announced the acceptance of two abstracts on new clinical data related to FORE8394, the company's novel, investigational, small-molecule, next-generation, orally available